Comparative Efficacy and Safety of Drug-Eluting Stent and Conventional Therapies in Coronary Heart Disease Patients with In-Stent Restenosis: A Meta-Analysis

Cell Biochemistry and Biophysics

Volumn 68, Issue 1, 2014, Pages 211-229

  Sun, Yuhan ^a   Li, Lang ^a   Su, Qiang ^a   Lu, Yongguang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Coronary heart disease; Drug eluting stent; In stent restenosis; Meta analysis

Indexed keywords

ARTICLE; CEREBRAL REVASCULARIZATION; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; FACTUAL DATABASE; HEART INFARCTION; HUMAN; META ANALYSIS; RADIOGRAPHY; RESTENOSIS; RISK; SEVERITY OF ILLNESS INDEX; STENT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; CEREBRAL REVASCULARIZATION; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DATABASES, FACTUAL; DEATH; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOSIS;

EID: 84891624370     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9692-7     Document Type: Article

References (43)

1. Liistro, F., Fineschi, M., Angioli, P., et al. (2006). Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: The TRUE (Tuscany registry of sirolimus for unselected in-stent restenosis) registry. Journal of the American College of Cardiology, 48, 270-275.
2. Aminian, A., Kabir, T., & Eeckhout, E. (2009). Treatment of drug-eluting stent restenosis: An emerging challenge. Catheterization and Cardiovascular Interventions, 74, 108-116.
3. Wijns, W., Kolh, P., Danchin, N., et al. (2010). Guidelines on myocardial revascularization. European Heart Journal, 31, 2501-2555.
4. Neumann, F. J., Desmet, W., Grube, E., et al. (2005). Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation, 111, 2107-2111.
5. Kastrati, A., Mehilli, J., von Beckerath, N., et al. (2005). Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA, 293, 165-171.
6. Holmes, D. R, Jr, Teirstein, P., Satler, L., et al. (2006). Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The SISR randomized trial. JAMA, 295, 1264-1273.
7. Stone, G. W., Ellis, S. G., O'Shaughnessy, C. D., et al. (2006). Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trial. JAMA, 295, 1253-1263.
8. Alfonso, F., Perez-Vizcayno, M. J., Hernandez, R., et al. (2006). A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: Results of the restenosis intrastent: Balloon angioplasty versus elective sirolimus-eluting stenting (RIBS-II) trial. Journal of the American College of Cardiology, 47, 2152-2160.
9. Unverdorben, M., Vallbracht, C., Cremers, B., et al. (2009). Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation, 119, 2986-2994.
10. Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery, 8, 336-341.
11. Ardissino, D., Cavallini, C., Bramucci, E., et al. (2004). Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: A randomized trial. JAMA, 292, 2727-2734.
12. Schukro, C., Syeda, B., Kirisits, C., et al. (2007). Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiotherapy and Oncology, 82, 18-23.
13. Alfonso, F., Perez-Vizcayno, M. J., Hernandez, R., et al. (2008). Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: Results of a pooled analysis of two randomized studies. Catheterization and Cardiovascular Interventions, 72, 459-467.
14. Ellis, S. G., O'Shaughnessy, C. D., Martin, S. L., et al. (2008). Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. European Heart Journal, 29, 1625-1634.
15. Park, S. W., Lee, S. W., Koo, B. K., et al. (2008). Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED study. International Journal of Cardiology, 131, 70-77.
16. Wiemer, M., Konig, A., Rieber, J., et al. (2011). Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: Clinical and ultrasound results from a randomised trial. EuroIntervention, 6, 687-694.
17. Ko, Y. G., Kim, J. S., Kim, B. K., et al. (2012). Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR Multicenter Registry Study [KISS]). American Journal of Cardiology, 109, 607-613.
18. Tagliareni, F., La Manna, A., Saia, F., Marzocchi, A., & Tamburino, C. (2010). Long-term clinical follow-up of drug-eluting stent restenosis treatment: Retrospective analysis from two high volume catheterisation laboratories. EuroIntervention, 5, 703-708.
19. Abe, M., Kimura, T., Morimoto, T., et al. (2010). Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher registry. Circulation, 122, 42-51.
20. Sardella, G., Colantonio, R., De Luca, L., et al. (2009). Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes. Journal of Cardiovascular Medicine, 10, 469-473.
21. Liistro, F., Fineschi, M., Grotti, S., et al. (2009). Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosis. EuroIntervention, 5, 454-459.
22. Zavalloni, D., Belli, G., Rossi, M. L., et al. (2006). Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: Clinical and angiographic outcomes. American Heart Journal, 152(908), e1-e7.
23. Torguson, R., Sabate, M., Deible, R., et al. (2006). Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. American Journal of Cardiology, 98, 1340-1344.
24. Sakamoto, H., Ishikawa, T., Mutoh, M., et al. (2006). Effectiveness of a sirolimus-eluting stent (Cypher) for diffuse in-stent restenosis inside a bare metal stent. International Heart Journal, 47, 651-661.
25. Pohl, T., Kupatt, C., Steinbeck, G., & Boekstegers, P. (2005). Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy. Zeitschrift fur Kardiologie, 94, 405-410.
26. Iofina E, Radke PW, Skurzewski P, et al. (2005). Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison. Heart91, 1584-1589.
27. Feres, F., Munoz, J. S., Abizaid, A., et al. (2005). Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis. American Journal of Cardiology, 96, 1656-1662.
28. Saia, F., Lemos, P. A., Hoye, A., et al. (2004). Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Catheterization and Cardiovascular Intervention, 62, 283-288.
29. Radke, P. W., Kobella, S., Kaiser, A., et al. (2004). Treatment of in-stent restenosis using a paclitaxel-eluting stent: Acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. European Heart Journal, 25, 920-925.
30. Airoldi, F., Rogacka, R., Briguori, C., et al. (2004). Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis. American Journal of Cardiology, 94, 1297-1300.
31. Lee, S. W., Park, S. W., Park, D. W., et al. (2007). Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis. American Journal of Cardiology, 100, 425-430.
32. Kim, Y. H., Lee, B. K., Park, D. W., et al. (2006). Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. American Journal of Cardiology, 98, 1451-1454.
33. Sheiban, I., Sillano, D., Biondi-Zoccai, G., et al. (2009). Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (failure in left main study). Journal of the American College of Cardiology, 54, 1131-1136.
34. Dibra, A., Kastrati, A., Alfonso, F., et al. (2007). Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: Meta-analysis of randomized trials. Journal of the American College of Cardiology, 49, 616-623.
35. Oliver, L. N., Buttner, P. G., Hobson, H., & Golledge, J. (2008). A meta-analysis of randomised controlled trials assessing drug-eluting stents and vascular brachytherapy in the treatment of coronary artery in-stent restenosis. International Journal of Cardiology, 126, 216-223.
36. Stone, G. W., Moses, J. W., Ellis, S. G., et al. (2007). Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. The New England Journal of Medicine, 356, 998-1008.
37. Spaulding, C., Daemen, J., Boersma, E., Cutlip, D. E., & Serruys, P. W. (2007). A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. The New England Journal of Medicine, 356, 989-997.
38. Kastrati, A., Mehilli, J., Pache, J., et al. (2007). Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. The New England Journal of Medicine, 356, 1030-1039.
39. Holmes, D. R, Jr, Teirstein, P. S., Satler, L., et al. (2008). 3-year follow-up of the SISR (sirolimus-eluting stents versus vascular brachytherapy for in-stent restenosis) trial. JACC Cardiovascular Intervention, 1, 439-448.
40. Rodriguez, A. E., & Waksman, R. (2009). Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (sirolimus-eluting stent versus vascular brachytherapy for in-stent restenosis) trial: A call for caution? JACC Cardiovascular Intervention, 2, 75-76.
41. Waksman, R., Ajani, A. E., Pinnow, E., et al. (2002). Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington radiation for in-stent restenosis trial (WRIST) 12 versus WRIST PLUS. Circulation, 106, 776-778.
42. Silber, S., Albertsson, P., Aviles, F. F., et al. (2005). Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European society of cardiology. European Heart Journal, 26, 804-847.
43. Lu, Y. G., Chen, Y. M., Li, L., Zhao, R. Z., Fu, C. H., & Yan, H. (2011). Drug-eluting stents vs. intracoronary brachytherapy for in-stent restenosis: A meta-analysis. Clinical Cardiology, 34, 344-351.